Comments
GSK clinches deal to buy Human Genome for $3 billion
17.07.2012. | LONDON/BOSTON (Reuters) - GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile pursuit of the U.S. biotech company....
